During the past decade, Aerie Pharmaceuticals conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aerie Pharmaceuticals" are "Ocular Hypertension" (5 trials) and "Open-angle Glaucoma" (5 trials). Many other conditions were trialed in "Aerie Pharmaceuticals" in a lesser frequency.

Most popular intervention types in "Aerie Pharmaceuticals" are "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "AR-13324 Ophthalmic Solution 0.02%" (3 trials), "Placebo" (3 trials), "PG324 Ophthalmic Solution 0.02%/0.005%" (2 trials), "Timolol maleate Ophthalmic Solution 0.5% BID" (2 trials) and "AR-13324 Ophthalmic Solution 0.02% BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aerie Pharmaceuticals" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Aerie Pharmaceuticals". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Aerie Pharmaceuticals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aerie Pharmaceuticals, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".